Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 121, Issue 8, Pages 3258-3268Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI46267
Keywords
-
Categories
Funding
- NIH
- Fondation Leducq's Transatlantic Network of Excellence in Cardiovascular Research Program
- Robert A. Welch Foundation [I-0025]
- American Heart Association
Ask authors/readers for more resources
MicroRNAs modulate cellular phenotypes by inhibiting expression of mRNA targets. In this study, we have shown that the muscle-specific microRNAs miR-133a-1 and miR-133a-2 are essential for multiple facets of skeletal muscle function and homeostasis in mice. Mice with genetic deletions of miR-133a-1 and miR-133a-2 developed adult-onset centronuclear myopathy in type II (fast-twitch) myofibers, accompanied by impaired mitochondrial function, fast-to-slow myofiber conversion, and disarray of muscle triads (sites of excitation-contraction coupling). These abnormalities mimicked human centronuclear myopathies and could be ascribed, at least in part, to dysregulation of the miR-133a target mRNA that encodes dynamin 2, a GTPase implicated in human centronuclear myopathy. Our findings reveal an essential role for miR-133a in the maintenance of adult skeletal muscle structure, function, bioenergetics, and myofiber identity; they also identify a potential modulator of centronuclear myopathies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available